Comac Medical
Private Company
Funding information not available
Overview
Comac Medical is a private, revenue-generating, full-service CRO headquartered in Sofia, Bulgaria, with approximately 350 employees. It provides end-to-end clinical trial services across all phases and therapeutic areas, with a strong geographic focus on Central/Eastern Europe and Eurasia. A key strategic move is its recent unification with ILIFE Consulting, enhancing its early-phase and oncology capabilities. The company differentiates itself through owned early-phase units, a bioanalytical lab, and a focus on patient recruitment speed in diverse populations.
Technology Platform
Integrated CRO service platform featuring a fully owned Early Phase Unit with co-located bioanalytical lab, and an extensive geographic network across Europe and Eurasia for patient recruitment and site management.
Pipeline
4| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Vaccine | Influenza | Phase 3 | |
| GB1211 + Placebo | Hepatic Impairment | Phase 1/2 | |
| CHF6467 active | Diabetic Neuropathic Foot Ulcers | Phase 1/2 | |
| Influenza vaccine, split inactivated | Influenza, Human | Phase 1 |
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CRO market, competing against large full-service players (e.g., IQVIA, ICON) and smaller specialized boutiques. Differentiates through a mid-sized, flexible partnership model, owned early-phase infrastructure, and deep regional expertise in Central/Eastern Europe and Eurasia.